SUZANNE THOMPSON: Open Payments
NPI 1003996273 · SHARON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,709 in 77 payments from 14 companies in 2025. Trend: 2023 $1,211 · 2024 $1,838 · 2025 $1,709
Food & beverage: $1,709
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $345 |
| Janssen Biotech, Inc. | 10 | $300 |
| Madrigal Pharmaceuticals | 7 | $212 |
| Aimmune Therapeutics, Inc. | 9 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $165 |
| Phathom Pharmaceuticals, Inc. | 6 | $118 |
| Lilly USA, LLC | 3 | $79 |
| Ardelyx, Inc. | 3 | $75 |
| Intra-Sana Laboratories | 2 | $73 |
| Exact Sciences Corporation | 3 | $58 |
Products named: TREMFYA, REZDIFFRA, ZENPEP, RINVOQ, ENTYVIO, VOQUEZNA, SKYRIZI, OMVOH.
Industry payments across CT — which companies pay providers there.
